Outlook Therapeutics (OTLK) Equity Income (2021 - 2026)
Outlook Therapeutics (OTLK) reported Equity Income of -$41,013 for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$30,884 a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Equity Income (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Outlook Therapeutics' Equity Income came in at -$165,185; for FY2025 (ended Sep 30, 2025), it was -$141,007.
- By fiscal year, Equity Income came in at -$100,742 in FY2024, -$10,998 in FY2023, -$48,730 in FY2022 and -$46,340 in FY2021.
- Five-year quarterly Equity Income spans a low of -$57,497 in fiscal Q3 2024 and a high of $389,006 in fiscal Q4 2021.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$45,119 (Q2 2026), -$38,634 (Q1 2026) and -$40,419 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -10.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 | -41,013.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41,013.00 |
| Mar 31, 2026 | -45,119.00 |
| Dec 31, 2025 | -38,634.00 |
| Sep 30, 2025 | -40,419.00 |
| Jun 30, 2025 | -30,884.00 |
| Mar 31, 2025 | -36,409.00 |
| Dec 31, 2024 | -33,295.00 |
| Sep 30, 2024 | -15,198.00 |
| Jun 30, 2024 | -57,497.00 |
| Mar 31, 2024 | -30,595.00 |
| Dec 31, 2023 | 2,548.00 |
| Sep 30, 2023 | -8,350.00 |
| Jun 30, 2023 | -7,188.00 |
| Mar 31, 2023 | -16,965.00 |
| Dec 31, 2022 | 21,505.00 |
| Sep 30, 2022 | -7,226.00 |
| Jun 30, 2022 | -11,805.00 |
| Mar 31, 2022 | -6,044.00 |
| Dec 31, 2021 | -23,655.00 |
| Sep 30, 2021 | 389,006.00 |
API Access
Outlook Therapeutics Equity Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=equity-income&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "equity-income", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=equity-income&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();